Review: Rescue percutaneous coronary intervention but not repeated fibrinolysis is effective for failed fibrinolysis in STEMI: COMMENTARY

Berger, Peter; Skelding, Kimberly
July 2007
ACP Journal Club;Jul/Aug2007, Vol. 147 Issue 1, p11
Academic Journal
The authors reflect on a study, conducted by H.C. Wijeysundera and colleagues, which focuses on the benefits and risks of rescue percutaneous coronary intervention (PCI) or repeated fibrinolytic therapy compared with conservative management in patients with ST-segment elevation myocardial infarction (STEMI) in whom fibrinolytic therapy fails. The authors view that the study failed to provide answer to the time from administration of fibrinolytic therapy.


Related Articles

  • Invasive strategy underused in ACS.  // Heart;Jun2008, Vol. 94 Issue 6, p818 

    The article presents a study on the application of invasive strategy in the treament of patients with acute coronary syndromes (ACS). The study investigated the selection of patients for cardiac catheterisation and used the Thrombolysis in Myocardial Infarction (TIMI) risk score. Results showed...

  • Effects of spironolactone on cardiac sympathetic nerve activity and left ventricular remodelling after reperfusion therapy in patients with first ST-segment elevation myocardial INFARCTION. Kasama, Shu; Toyama, Takuji; Sumino, Hiroyuki; Kumakura, Hisao; Takayama, Yoshiaki; Minami, Kazutomo; Ichikawa, Shuichi; Matsumoto, Naoya; Sato, Yuichi; Kurabayashi, Masahiko // Heart;May2011, Vol. 97 Issue 10, p8 

    The article discusses a study to evaluate the hypothesis that spironolactone improves the cardiac sympathetic nerve activity (CSNA) in patients with a first ST-segment elevation myocardian infarction (STEMI) undergoing primary coronary angioplasty. Patients admitted to the coronary care unit...

  • Is the National Service Framework standard for thrombolytic therapy achievable in a rural area? A-M. Harney; R. McClean; J. Rawles; D. Stewart // Journal of Public Health Medicine;Mar2003, Vol. 25 Issue 1, p19 

    The National Service Framework (NSF) for coronary heart disease requires that patients with acute myocardial infarction should start thrombolytic therapy within 60 min of the patient making contact with the National Health Service. In an audit of 700 patients with suspected acute myocardial...

  • Left ventricular thrombus formation after acute myocardial infarction. Delewi, Ronak; Zijlstra, Felix; Piek, Jan J. // Heart;Dec2012, Vol. 98 Issue 23, p1742 

    The article offers information on the risks related to the formation of left ventricular (LV) thrombus after the occurrence of acute myocardial infarction (AFI). It informs that the risk of LV thrombus formation is highest during the first 3 months of following acute myocardial infarction. It...

  • The effect of patients' time of arrival at the hospital on the rate of Thrombolytic therapy. Kazemi, Toba; Sharifzadeh, Gholam-Reza; Neikhonjy, Samaneh // ARYA Atherosclerosis;2013, Vol. 9 Issue 1, Special section p1 

    The article discusses a study which examined the effect of the arrival time of patients at the hospital on the rate of thrombolytic therapy. It was conducted on patients with ST segment elevation myocardial infarction or heart attack (STEMI) at Birjand Vali-e Asr Hospital in Iran. It relates the...

  • The Efficacy Of An Adjusted Timi Risk Score In The Evalauation Of Patients With Chest Pain Presenting To A Public Hospital. Webb, Tamy L. // Internet Journal of Academic Physician Assistants;2007, Vol. 5 Issue 2, p2 

    Risk stratification has been proven to be effective in some populations to evaulate chest pain, but does it apply to a population from a lower socioeconomic status, specifically in the south? This study is designed to test an adjusted version of the Thrombolysis in Myocardial Infarction risk...

  • JournalScan. Malik, Iqbal // Heart;Jun2002, Vol. 87 Issue 6, p590 

    This article presents research results related to heart disease. In a cohort of over 2000 patients, more than 75 years old who had a myocardial infarction, only 63% of eligible patients got thrombolysis while 27% of thrombolysis recipients had what are regarded as absolute contraindications to...

  • The Efficacy Of Thrombolytic Treatment On Patients Who Are Above 75 Years Of Age. Keles, Telat; Akar, Nihal; Gürsel, Koray; Canbay, Alper; Şahin, Deniz; Durmaz, Tahir; Diker, Erdem; Aydogdu, Sinan // Internet Journal of Cardiology;2006, Vol. 3 Issue 1, p2 

    Background: For acute myocardial infarction (AMI) patients above the age of 75, the efficacy of thrombolytic treatment could not be demonstrated clearly. Recently, depending on the data obtained from observational studies, it has been advocated that thrombolytic treatment might not be showing...

  • Coronary blood flow in patients with end-stage renal disease assessed by thrombolysis in myocardial infarction frame count method. Sobkowicz, Bozena; Tomaszuk-Kazberuk, Anna; Kralisz, Pawel; Malyszko, Jolanta; Kalinowski, Marek; Hryszko, Tomasz; Sawicki, Robert; Dobrzycki, Slawomir; Musial, Wlodzimierz J. // Nephrology Dialysis Transplantation;Mar2010, Vol. 25 Issue 3, p926 

    Background. Myocardial ischaemia in patients with end-stage renal disease (ESRD) develops both due to the epicardial coronary artery stenosis and to the microvascular injury. We aimed to evaluate coronary blood flow in ESRD patients by means of the thrombolysis in myocardial infarction (TIMI)...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics